TRAM 39 structure
|
Common Name | TRAM 39 | ||
---|---|---|---|---|
CAS Number | 197525-99-8 | Molecular Weight | 303.78500 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C20H14ClN | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of TRAM 39TRAM-39 is a selective blocker of intermediate conductance Ca2+-activated K+ (IKCa) channels. TRAM-39 inhibits KCa3.1 channel with an IC50 value of 60 nM. TRAM-39 can be used for the research of ataxia, epilepsy, memory disorders, schizophrenia and Parkinson’s disease[1][2][3][4]. |
Name | 2-(2-chlorophenyl)-2,2-diphenylacetonitrile |
---|---|
Synonym | More Synonyms |
Description | TRAM-39 is a selective blocker of intermediate conductance Ca2+-activated K+ (IKCa) channels. TRAM-39 inhibits KCa3.1 channel with an IC50 value of 60 nM. TRAM-39 can be used for the research of ataxia, epilepsy, memory disorders, schizophrenia and Parkinson’s disease[1][2][3][4]. |
---|---|
Related Catalog | |
Target |
IC50: 60 nM (KCa3.1 channel)[4] |
In Vitro | TRAM-39 (1 μM) reduces the peak amplitude of gKCa2 in sympathetic LAH neurons (mean percentage change 56%) in BAE cells[2]. TRAM-39 (200 nM) diminishes lipopolysaccharide (LPS)-induced cryptdin release from paneth cells[3]. |
In Vivo | TRAM-39 (1 μM; adds to the perfusate) fully blocks all IKCa channels in multicellular preparations[1]. |
Molecular Formula | C20H14ClN |
---|---|
Molecular Weight | 303.78500 |
Exact Mass | 303.08100 |
PSA | 23.79000 |
LogP | 5.19798 |
Storage condition | -20°C |
(2-chlorophenyl)-diphenylacetonitrile |
TRAM-39 |
TRAM 39 |